Evidence map›Paper›PMID 39819487›Full record

ArticleEuropean thyroid journal2025

The relationship between cholesterol levels and thyroid eye disease.

Caroline Cardo, Roberto Bernardo Santos, Ana Beatriz Pinotti Pedro Miklos, Sabrina Barbosa Jaconis, João Hamilton Romaldini, Danilo Villagelin

Registry-linked trialAbstract read
In one paragraph

Article in European thyroid journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07400757 (The Role of Statin and Vitamin D for the Treatment of Thyroid Eye Disease), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07400757 narecruitingnot on this mapstarted 2026, after this paper: background citation

The Role of Statin and Vitamin D for the Treatment of Thyroid Eye Disease

TypeinterventionalSponsorTaipei Veterans General Hospital, TaiwanRan2026 to 2032Enrolled120ConditionsThyroid Eye Disease, TED, Graves OphthalmopathyArmsAtorvastatin (Lipitor), Vitamin D
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caroline CardoPostgraduate Course Internal Medicine, Campinas State University, Campinas. Brazil. Endocrinology and Metabolism, Hospital PUC-Campinas, Campinas, Brazil.ORCID 0009-0003-0658-4203
Roberto Bernardo SantosEndocrinology and Metabolism, Hospital PUC-Campinas, Campinas, Brazil.
Ana Beatriz Pinotti Pedro MiklosEndocrinology and Metabolism, São Paulo State Public Servant Hospital (IAMSPE), São Paulo, Brazil.
Sabrina Barbosa JaconisInternal Medicine, Hospital PUC-Campinas, Campinas, Brazil.
João Hamilton RomaldiniEndocrinology and Metabolism, Hospital PUC-Campinas, Campinas, Brazil.
Danilo VillagelinPostgraduate Course Internal Medicine, Campinas State University, Campinas., Brazil. Medical School, Pontifical Catholic University of Campinas, Campinas, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Thyroid eye disease (TED) is the most prevalent extrathyroidal manifestation of Graves' disease (GD). Emerging evidence suggests a relationship between elevated total and low-density lipoprotein (LDL) cholesterol levels and TED. This study aimed to investigate this correlation in the Brazilian population by analyzing data from two tertiary care centers. Methods: Data were collected from GD patients treated with methimazole between 1999 and 2021, excluding those receiving other treatments. Laboratory results and information on smoking habits, statin use and medications affecting lipid profiles during the euthyroid state were analyzed. Results: Smoking and elevated LDL cholesterol levels were significantly associated with TED activity and severity. Logistic regression revealed correlations between higher LDL cholesterol, total cholesterol and increased clinical activity score (P < 0.01, OR: 1.012, 95% CI: 1.003-1.021; P < 0.01, OR: 1.010, 95% CI: 1.002-1.018). These were also associated with more severe disease forms as defined by EUGOGO (P < 0.01, OR: 1.015, 95% CI: 1.006-1.024; P < 0.005, OR: 1.011, 95% CI: 1.004-1.019). Multiple regression confirmed that TED activity was significantly correlated with LDL cholesterol (P < 0.01) and smoking status (P < 0.01). Disease severity was associated with reduced HDL cholesterol (P < 0.05, OR: 0.973, 95% CI: 0.948-0.999), elevated LDL cholesterol (P < 0.005, OR: 1.013, 95% CI: 1.004-1.023) and active smoking (P < 0.05, OR: 2.881, 95% CI: 1.190-6.971). Conclusion: Elevated LDL cholesterol may serve as a potential indicator of TED. Further research is needed to determine whether lipid-lowering interventions could reduce TED risk or improve its management.

Indexed as

CholesterolCholesterol, LDLGraves OphthalmopathyAdultAgedAntithyroid AgentsBrazilFemaleHumansLogistic ModelsMaleMethimazoleMiddle AgedSeverity of Illness IndexSmokingAntithyroid AgentsCholesterolCholesterol, LDLMethimazolecholesterolGraves’ diseasehyperthyroidismthyroid eye disease

Identifiers

PMID39819487
PMCPMC11825156

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.